Harvard Bioscience (HBIO) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts HBIO Hot Sheet
Price: $6.66 -0.15%
Financial Fact:
Sales and marketing expenses: 5.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Sales and marketing expenses: 5.01M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Harvard Bioscience (NASDAQ: HBIO) reported Q4 EPS of $0.04, $0.01 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $28.4 million versus the consensus estimate of $30.4 million.
For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
